257 related articles for article (PubMed ID: 35797441)
21. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.
Hing JX; Chua YN; Tan PT; Tan MSL; Mok CW; Seet MYL; Lin ZC; Seah CM; Lee WP; Tan SM
Ann Acad Med Singap; 2024 Feb; 53(2):80-89. PubMed ID: 38920232
[TBL] [Abstract][Full Text] [Related]
22. Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy.
Sayan M; Kilic SS; Vergalasova I; Jan I; Eladoumikdachi F; Haffty B; Kumar S; Ohri N
Clin Breast Cancer; 2022 Aug; 22(6):553-559. PubMed ID: 35589489
[TBL] [Abstract][Full Text] [Related]
23. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
[No Abstract] [Full Text] [Related]
24. Preventing Breast Cancer-Related Lymphedema in High-Risk Patients: The Impact of a Structured Surveillance Protocol Using Bioimpedance Spectroscopy.
Whitworth PW; Shah C; Vicini F; Cooper A
Front Oncol; 2018; 8():197. PubMed ID: 29946531
[TBL] [Abstract][Full Text] [Related]
25. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
[TBL] [Abstract][Full Text] [Related]
26. The Early Detection of Breast Cancer Treatment-Related Lymphedema of the Arm.
Keeley V
Lymphat Res Biol; 2021 Feb; 19(1):51-55. PubMed ID: 33270493
[No Abstract] [Full Text] [Related]
27. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the Association Between Breast Cancer-Related Lymphedema and the Side Effects of Taxane-Based Chemotherapy Using Indocyanine Green Lymphography.
Tokumoto H; Akita S; Nakamura R; Yamamoto N; Kubota Y; Mitsukawa N
Lymphat Res Biol; 2022 Dec; 20(6):612-617. PubMed ID: 35099282
[No Abstract] [Full Text] [Related]
29. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
30. Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.
Bucci LK; Brunelle CL; Bernstein MC; Shui AM; Gillespie TC; Roberts SA; Naoum GE; Taghian AG
Ann Surg Oncol; 2021 Dec; 28(13):8624-8633. PubMed ID: 34117574
[TBL] [Abstract][Full Text] [Related]
31. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
[TBL] [Abstract][Full Text] [Related]
32. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema.
Forte AJ; Huayllani MT; Boczar D; Avila FR; Kassis S; Ciudad P; Lu X; Moore PA; McLaughlin SA
Breast Dis; 2021; 40(2):85-93. PubMed ID: 33646139
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
34. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
35. The Impact of L-Dex(®) Measurements in Assessing Breast Cancer-Related Lymphedema as Part of Routine Clinical Practice.
Laidley A; Anglin B
Front Oncol; 2016; 6():192. PubMed ID: 27656420
[TBL] [Abstract][Full Text] [Related]
36. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
Brunelle CL; Roberts SA; Shui AM; Gillespie TC; Daniell KM; Naoum GE; Taghian A
J Surg Oncol; 2020 Aug; 122(2):155-163. PubMed ID: 32497273
[TBL] [Abstract][Full Text] [Related]
37. Body Mass Index as a Major Risk Factor for Severe Breast Cancer-Related Lymphedema.
Leray H; Malloizel-Delaunay J; Lusque A; Chantalat E; Bouglon L; Chollet C; Chaput B; Garmy-Susini B; Yannoutsos A; Vaysse C
Lymphat Res Biol; 2020 Dec; 18(6):510-516. PubMed ID: 32283042
[No Abstract] [Full Text] [Related]
38. Body mass index increases the risk of breast cancer-related lymphedema at 6-18 months after surgery: a retrospective study.
Wang L; Chen H; Li Y; Wang H; Liu N; Yu M; Shang S
Support Care Cancer; 2023 Apr; 31(5):278. PubMed ID: 37074508
[TBL] [Abstract][Full Text] [Related]
39. Lymph node status and breast cancer-related lymphedema.
Purushotham AD; Bennett Britton TM; Klevesath MB; Chou P; Agbaje OF; Duffy SW
Ann Surg; 2007 Jul; 246(1):42-5. PubMed ID: 17592289
[TBL] [Abstract][Full Text] [Related]
40. Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.
Thomis S; Devoogdt N; Bechter-Hugl B; Fourneau I
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
